News:
RFK Jr. on Ozempic, Eli Lilly's next test, and Elon Musk gets on the bandwagon: Pharma news roundup - PCB levies 31L penalty on pharma manufacturing unit over violations - Healthy Returns: Trump's FDA pick Makary may be a relief for biotech and pharma, analysts say - Ozempic cuts drinking, Zepbound beats Wegovy, and a blood test detects 50 cancers: Pharma news roundup - T govt scraps pharma city plan amid protests, announces textile corridor - No pharma city, Kodangal to have industrial corridor: CM - T'gana pharma biggies to inject 5,200cr in Pharma City, create over 12,000 jobs - Pharma shares hit as Trump picks RFK Jr to lead health department - What the NFL Draft Can Teach Investors About Big Pharma - A stronger Ozempic, Wegovy sales boom, and Hims' generic weight loss drug: Pharma news roundup
Pharmadar
Bookmark
ShareKey facts
- sector: Health Care
- foundation year: 2013
- industry: Pharmaceuticals
Classified as: organization
Summary
Pharmadar is a company. It was founded in 2013. The company is part of the Health Care sector, specifically in the Pharmaceuticals industry.
Business
Pharmadar is one of the companies in Pharmaceuticals, companies in Health Care and 3,466,499 companies in our database.
Stocks from Pharmadar
Explore more on business
Talking Points:
Learn more about talking points